plant
biotechnolog
experienc
exponenti
develop
past
year
facilit
larg
part
capac
clever
soil
bacterium
agrobacterium
tumefacien
transfer
dna
segment
plant
cell
gelvin
power
function
har
clever
plant
biologist
enabl
routin
deliveri
recombin
dna
plant
cell
among
thing
product
recombin
protein
plant
use
plant
express
subunit
vaccin
antigen
first
pursu
earli
curtiss
cardineau
mason
et
al
natur
outgrowth
emerg
technolog
come
soon
groundbreak
demonstr
immunoglobulin
could
produc
transgen
tobacco
hiatt
et
al
interest
reader
refer
recent
review
articl
describ
advanc
use
plant
product
deliveri
vaccin
antigen
mason
herbstkralovetz
pelosi
et
al
rybicki
rybicki
streatfield
tacket
yusibov
et
al
thanavala
et
al
yusibov
rabindran
unfortun
commerci
develop
plantderiv
vaccin
product
slow
perhap
due
conserv
pharmaceut
industri
hesit
tri
new
technolog
hypothesi
drove
much
earli
work
plantderiv
vaccin
held
cheap
oral
deliv
edibl
subunit
vaccin
could
provid
protect
infecti
diseas
develop
countri
limit
medic
infrastructur
thu
ingest
plant
materi
would
stimul
protect
immun
mediat
uptak
process
antigen
gutassoci
lymphoid
tissu
galt
streatfield
thanavala
et
al
number
hurdl
interfer
effect
approach
includ
poor
stabil
protein
gut
substanti
variabl
antigen
content
plant
tissu
regulatori
concern
contain
transgen
crop
plant
use
exclus
pharmaceut
product
issu
discuss
greater
detail
paper
mason
herbstkralovetz
rybicki
rybicki
et
al
challeng
notwithstand
worker
watcher
field
continu
see
great
valu
use
plant
product
vaccin
antigen
importantli
compel
data
protect
efficaci
oral
deliv
plantderiv
vaccin
antigen
continu
accumul
discuss
detail
section
anim
vaccin
approach
plantbas
protein
express
includ
stabli
integr
transgen
chromosom
either
nucleu
chloroplast
transient
express
use
vector
may
use
plant
viru
replic
element
amplifi
transgen
present
brief
discuss
interest
reader
refer
excel
recent
review
articl
rybicki
thuenemann
et
al
nuclear
gene
inherit
mendelian
fashion
wherea
chloroplast
gene
pass
progeni
matern
parent
sinc
pollen
cell
devoid
chloroplast
tissuespecif
promot
allow
foreign
protein
accumul
seed
nochi
et
al
streatfield
see
discuss
mucoric
protein
accumul
seed
stabl
temperatur
extrem
store
month
year
littl
loss
protein
activ
past
decad
use
rapid
transient
express
plant
rather
slow
product
plant
stabli
integr
transgen
increas
greatli
repres
evergrow
proport
plantbas
protein
express
work
develop
viral
vector
enabl
fast
high
level
protein
express
plant
thuenemann
et
al
gleba
et
al
yusibov
et
al
nicotiana
benthamiana
tobacco
rel
goodin
et
al
typic
plant
host
due
eas
cultur
effect
support
plant
viru
replic
protein
express
level
mg
per
kilogram
leaf
mass
often
higher
obtain
stabli
transgen
plant
indic
potenti
purif
plantproduc
protein
cost
econom
competit
microbi
ferment
system
moreov
cultur
n
benthamiana
readili
scale
massiv
level
pogu
et
al
kentucki
bioprocess
inc
owensboro
ky
http
wwwkbpllccom
develop
largescal
system
plant
growth
infiltr
agrobacterium
purif
recombin
protein
figur
conveni
transient
plantbas
express
enabl
rapid
respons
emerg
virus
influenza
noroviru
describ
charl
arntzen
address
nation
meet
american
chemic
societi
dylewski
develop
make
plantbas
express
purif
vaccin
antigen
includ
viruslik
particl
vlp
huang
et
al
santi
et
al
mucos
deliveri
commerci
viabl
also
util
purifi
antigen
intranas
deliveri
requir
concentr
antigen
lower
dose
oral
deliveri
nasal
immun
induc
antigenspecif
mucos
iga
respons
salivari
gland
respiratori
tract
intestin
reproduct
tract
mammal
harandi
et
al
imaoka
et
al
kozlowski
et
al
rudin
et
al
staat
et
al
moreov
mucos
immun
prime
mucos
system
immun
respons
kunkel
butcher
thu
intranas
deliveri
plantderiv
vaccin
antigen
especi
vlp
promis
strategi
discuss
chapter
describ
progress
select
area
mucos
vaccin
human
anim
host
focu
studi
involv
human
shown
strong
indic
efficaci
preclin
studi
norovirus
causal
agent
epidem
gastroenter
sometim
call
stomach
flu
occur
ocean
liner
cruis
ship
viru
dylewski
founder
loss
power
ship
noroviru
epidem
projectil
vomit
persist
diarrhea
must
one
disappoint
vacat
imagin
yet
vaccin
avail
noroviru
much
work
past
year
focus
product
immunogen
test
noroviru
vlp
nvlp
capsid
protein
nvcp
assembl
vlp
express
insect
cell
jiang
et
al
plant
mason
et
al
vlp
substanti
acid
stabl
thu
amen
oral
deliveri
preclin
studi
transgen
tobacco
potatoderiv
nvlp
deliv
oral
mice
show
effici
product
antigenspecif
serum
igg
fecal
iga
mason
et
al
clinic
trial
test
feed
human
volunt
g
raw
potato
tuber
tissu
contain
nvcp
two
three
dose
period
week
indic
promis
result
tacket
et
al
nearli
subject
ingest
nvcp
potato
develop
antigenspecif
serum
igg
andor
iga
respons
titer
modest
compar
obtain
later
studi
purifi
insect
cellderiv
nvlp
tacket
et
al
difficulti
raw
potato
vehicl
variabl
amount
nvcp
among
differ
tuber
sampl
limit
effici
vlp
assembl
thu
purifi
nvlp
prefer
materi
oral
vaccin
deliveri
transgen
tomato
fruit
express
nvcp
prove
tractabl
system
zhang
et
al
freezedri
tissu
transgen
tomato
fruit
potato
tuber
fed
mice
tomato
shown
superior
vehicl
four
dose
g
dri
tomato
nvcp
nvlp
caus
seroconvers
mice
doubl
amount
result
furthermor
excel
level
antinvcp
fecal
iga
induc
seroconvert
mice
convers
similar
dose
freezedri
potato
produc
substanti
poorer
result
probabl
due
oxid
phenol
compound
abund
potato
tuber
sinc
tomato
fruit
low
phenol
high
antioxid
ascorb
acid
oxid
effect
minim
although
tomato
deliveri
strategi
seem
ripe
develop
wind
chang
blow
bring
faster
robust
transient
express
system
becam
appar
nvlp
transient
express
leav
could
purifi
consist
high
yield
qualiti
huang
et
al
santi
et
al
stabl
transgen
system
larg
left
behind
descript
process
produc
nvlp
current
good
manufactur
practic
cgmp
condit
lai
chen
pave
way
futur
clinic
studi
like
occur
soon
charl
arntzen
person
commun
meanwhil
sever
interest
studi
investig
intranas
deliveri
plantderiv
nvlp
mice
show
strong
effect
tolllik
receptor
agonist
mucos
adjuv
cpg
oligodeoxynucleotid
cpg
odn
known
interact
stimul
matur
prolifer
multipl
cell
type
immun
system
provid
strong
vaccin
adjuv
effect
abe
et
al
purifi
plantderiv
nvlp
deliv
mice
two
dose
given
week
apart
much
stronger
serum
mucos
antibodi
respons
obtain
cpg
odn
codeliv
nvlp
mason
herbstkralovetz
mucos
antinvlp
iga
respons
measur
multipl
epitheli
site
includ
intestin
vagin
secret
strongli
enhanc
adjuv
effect
moreov
deliveri
nvlp
without
adjuv
vastli
superior
oral
deliveri
nvlp
product
antigenspecif
serum
igg
data
make
compel
case
deliveri
nvlp
could
make
efficaci
vaccin
support
case
deliveri
vlp
vaccin
sexual
transmit
diseas
balmelli
et
al
viabl
strategi
herbstkralovetz
cowork
studi
effect
immun
mice
nvlp
adjuv
includ
agonist
velasquez
et
al
test
resiquimod
agonist
fdaapprov
clinic
trial
relat
midazoquinolinebas
agonist
gardiquimod
compar
cholera
toxin
ct
strong
riski
mucos
adjuv
experiment
gold
standard
experi
similar
describ
cpg
adjuv
gardiquimod
provok
antinvcp
serum
igg
mucos
iga
respons
intestin
respiratori
reproduct
mucosa
par
ct
superior
thu
agonist
produc
excel
mucos
immun
respons
intestin
vagin
site
distal
nasal
deliveri
site
herbstkralovetz
cowork
also
studi
murabutid
vaccin
adjuv
plantderiv
nvlp
deliv
mice
jackson
herbstkralovetz
murabutid
synthet
immunomodul
deriv
muramyl
dipeptid
mdp
smallest
bioactiv
unit
bacteri
peptidoglycan
unlik
mdp
murabutid
pyrogen
activ
thu
safer
murabutid
recogn
nucleotid
bind
oligomer
domaincontain
protein
receptor
mammalian
cell
approv
test
sever
clinic
trial
inject
vaccin
adjuv
jackson
herbstkralovetz
show
potent
mucos
adjuv
well
induc
serum
mucos
antinvlp
antibodi
deliveri
murabutid
test
deliv
nvlpdose
show
adjuv
activ
dose
optim
moreov
mucos
adjuv
activ
compar
gardiquimod
agonist
ct
suffer
safeti
concern
thu
murabutid
adjuv
indeliv
nvlp
excel
candid
clinic
evalu
studi
plantderiv
nvlp
test
adjuv
effect
gell
polysaccharid
deriv
plant
alo
vera
velasquez
et
al
product
call
gelsit
manufactur
cgmp
nanotherapeut
http
wwwnanotherapeuticscomproductspipelinegelvacphp
highmolecularweight
anion
polysaccharid
sodium
polygalacturon
prepar
liquid
process
make
dri
powder
formul
call
creat
gel
whether
liquid
powder
form
upon
contact
bodi
fluid
site
administr
gelvac
dri
formul
nvlp
deliv
mice
produc
antinvlp
serum
mucos
antibodi
titer
higher
liquid
formul
latter
could
improv
addit
gardiquimod
adjuv
still
similar
gelvac
presum
mucos
adjuv
activ
polygalacturon
deriv
depot
effect
prevent
drain
ciliari
clearanc
indeliv
materi
away
lymphoid
effector
site
nasal
mucosa
charl
arntzen
collabor
advanc
bionutrit
abn
http
wwwadvancedbionutritioncom
defaultaspx
evalu
noroviru
oral
vaccin
formul
goal
enter
human
clinic
trial
oral
deliveri
formul
support
us
patent
make
use
bioadhes
materi
order
enhanc
effici
oral
deliveri
human
immunodefici
viru
hiv
wellknown
fear
infecti
agent
target
lymphocty
ultim
result
loss
adapt
immun
system
function
monument
attempt
past
year
research
worldwid
develop
vaccin
result
date
modest
best
number
studi
use
plant
recombin
express
hiv
antigen
consensu
opinion
among
plantbas
vaccinologist
hold
mucos
immun
respons
import
crucial
protect
efficaci
thu
often
focu
deliveri
antigen
mucos
site
review
select
work
reader
direct
extens
review
articl
meyer
et
al
yusibov
et
al
inform
mani
plantbas
effort
hiv
vaccin
util
vlp
mean
increas
antigen
densiti
provid
repeat
antigen
array
effect
engag
bcell
receptor
interest
earli
exampl
use
potato
viru
x
pvx
produc
chimer
plant
viru
particl
display
highli
conserv
eldkwa
epitop
hiv
glycoprotein
marus
et
al
epitop
code
sequenc
fuse
nterminu
pvx
coat
protein
recombin
viru
use
infect
n
benthamiana
plant
result
robust
product
chimer
viru
particl
purifi
viru
use
immun
mice
either
intraperitoni
ip
mucos
without
adjuv
result
serum
igg
iga
specif
eldkwa
author
also
use
mous
model
human
immun
sever
combin
immunodefici
mice
reconstitut
human
peripher
blood
lymphocyt
hupblscid
immun
human
autolog
monocytederiv
dendrit
cell
puls
chimer
eldkwa
viru
particl
serum
normal
hupblscid
mice
neutral
demonstr
potenti
protect
hiv
infect
author
suggest
pvx
chimer
particl
system
could
also
use
tcell
epitop
howev
interest
note
even
lowtit
antibodi
could
protect
nonhuman
primat
repeat
lowdos
mucos
exposur
shiv
hessel
et
al
suggest
neutral
antibodi
alon
may
least
partial
protect
mor
colleagu
also
pursu
hiv
peptid
deriv
fuse
eldkwa
epitop
cholera
toxin
b
subunit
ctb
order
achiev
target
mucos
epithelium
matoba
et
al
mice
immun
ctbeldkwa
produc
escherichia
coli
develop
serum
mucos
fecal
antibodi
inhibit
transcytosi
vitro
author
demonstr
express
fusion
protein
n
benthamiana
test
immunogen
product
later
mor
colleagu
creat
stabl
transgen
plant
line
express
ctb
fusion
contain
longer
segment
membran
proxim
region
call
ctbmpr
matoba
et
al
perform
extens
character
purifi
fusion
protein
includ
glycan
analysi
found
asparaginelink
glycosyl
consensu
site
ctb
sequenc
glycan
found
bacteri
express
ctb
interfer
gangliosid
bind
display
hiv
epitop
mice
immun
liposomeconjug
ctbmpr
cholera
toxin
consecut
week
boost
ip
ctbmpr
week
produc
substanti
serum
igg
vagin
iga
specif
mpr
thu
one
expect
need
balanc
advantag
mucos
target
afford
ctb
overpow
immunogen
mor
colleagu
recent
turn
differ
strategi
plantbas
hiv
vaccin
vlp
compris
gag
kessan
et
al
press
figur
creat
stabli
transgen
n
benthamiana
express
hiv
gag
show
gag
vlp
accumul
plant
process
remain
mostli
kda
protein
use
icon
tmvbase
replicon
express
deconstruct
compris
membran
proxim
extern
region
mper
transmembran
domain
cytoplasm
tail
transgen
gag
plant
result
accumul
leav
vlp
contain
gag
evid
vlp
format
includ
electron
micrograph
show
particl
form
plasma
membran
endosom
extracellular
space
moreov
antigen
cosedi
rate
zonal
densiti
gradient
worker
immun
mice
particl
prepar
ctbmpr
prime
ip
one
antigen
week
boost
ip
week
figur
mice
prime
boost
vlp
show
strong
antigag
serum
igg
mice
respond
week
respons
less
impress
seven
eight
mice
seroconvert
week
vlp
prime
boost
mice
prime
either
vlp
ctbmpr
boost
antigen
seroconvert
week
immun
adjuv
ribi
adjuv
sigma
final
concentr
oil
suggest
good
mucos
adjuv
need
vlp
use
deliveri
anoth
vlp
approach
plantbas
hiv
vaccin
use
membran
particl
gener
fusion
hepat
b
surfac
antigen
hbsag
hbsag
express
plant
cell
insert
er
membran
invagin
form
particl
within
er
lumen
smith
et
al
transgen
potato
tuber
express
hbsag
oral
immunogen
mice
richter
et
al
human
thanavala
et
al
see
thu
hbsag
fusion
seem
reason
strategi
one
fusion
tbihbsag
encod
artifici
polypeptid
compos
sever
immunogen
tand
bcell
epitop
env
gag
protein
fuse
nterminu
hbsag
small
protein
shchelkunov
et
al
worker
gener
stabl
transgen
tomato
plant
freezedri
fruit
oral
deliveri
mice
tomato
powder
suspend
water
gavag
mice
dose
ng
antigen
ml
three
time
period
mice
boost
day
use
plasmid
dna
encod
tbihbsag
time
cours
antihbsag
antibodi
rapidli
accumul
serum
fecal
sampl
increas
boost
dna
vaccin
antihiv
respons
modest
measur
serum
fece
although
endpoint
titer
perform
nonetheless
result
look
promis
sala
colleagu
aim
elicit
cellular
immun
respons
use
polyepitop
compris
eight
hlaa
restrict
class
epitop
identifi
five
major
protein
gag
proteas
revers
transcriptas
integras
fuse
nterminu
hbsag
small
protein
cterminu
hbsag
domain
greco
et
al
guetard
et
al
gener
stabli
transgen
tobacco
plant
express
fusion
protein
fed
hsb
human
transgen
mice
restrict
epitop
present
human
class
mhc
allel
mous
knockout
background
ten
day
ingest
freezedri
transgen
tobacco
eight
dose
week
mice
prime
plasmid
express
fusion
protein
treatment
produc
tcell
activ
mesenter
lymph
node
indic
potenti
develop
specif
cytotox
tcellmedi
immun
howev
author
also
found
signific
activ
regulatori
cell
anim
suggest
potenti
develop
figur
model
hiv
virion
deconstruct
viruslik
particl
vlp
hiv
virion
left
contain
core
gag
capsid
enclos
rna
genom
segment
gag
matrix
protein
associ
lipid
membran
deriv
host
cell
plasma
membran
envelop
glycoprotein
kessan
et
al
describ
vlp
right
made
plant
coexpress
gag
deconstruct
lack
compon
thu
expos
membran
proxim
extern
epitop
conserv
capabl
induc
hivneutr
antibodi
toler
conflict
result
indic
one
must
care
interpret
result
feed
studi
hepat
b
viru
hbv
infect
may
lead
liver
cancer
million
death
per
year
worldwid
hbv
transmit
sexual
contact
birth
infect
mother
mucos
immun
would
enhanc
system
protect
provid
inject
yeastderiv
bsag
vaccin
mcaleer
et
al
larg
volum
work
past
year
demonstr
express
hbsag
varieti
plant
system
includ
potato
lettuc
tomato
tomatillo
corn
banana
streatfield
recent
review
articl
provid
good
survey
field
shchelkunov
shchelkunova
hbsag
express
plant
first
demonstr
transgen
tobacco
mason
et
al
transgen
potato
tuber
richter
et
al
use
demonstr
oral
immunogen
mice
kong
et
al
antibodi
titer
without
cholera
toxin
adjuv
modest
subimmunogen
prime
dose
yeastderiv
hbsag
requir
enabl
demonstr
boost
effect
fed
hbsag
potato
subsequ
clinic
trial
show
previous
vaccin
subject
ate
g
raw
potato
dose
hbsag
substanti
boost
serum
antihbsag
titer
thanavala
et
al
data
indic
oral
deliveri
hbsag
could
use
booster
vaccin
sinc
subject
experienc
boost
effect
year
intramuscular
vaccin
smaller
studi
show
two
human
subject
seroconvert
eat
transgen
lettuc
leav
contain
submicrogram
quantiti
hbsag
kapusta
et
al
although
neither
studi
use
adjuv
unless
one
consid
possibl
compound
found
either
potato
lettuc
could
function
interest
studi
oral
immunogen
mice
alumadsorb
yeastderiv
vaccin
low
dose
longer
interv
show
effici
seroconvers
kapusta
et
al
suggest
studi
low
dose
longer
interv
would
yield
better
result
oral
deliveri
hbsag
immun
toler
alway
potenti
concern
antigen
deliv
oral
need
studi
human
transgen
mice
allel
oral
deliveri
differ
dose
transgen
hbsag
tobacco
result
increas
level
regulatori
cell
treg
associ
toler
increas
hbsag
dose
kostrzak
et
al
press
serum
fecal
igg
iga
correl
invers
antigen
dose
suggest
oral
toler
occur
higher
dose
howev
rel
poor
antibodi
respons
made
correl
somewhat
tenuou
treg
increas
substanti
mice
immun
wildtyp
tobacco
nonetheless
group
eight
mice
prime
ip
either
ctbmpr
vlp
week
subsequ
boost
ip
either
ctbmpr
vlp
week
number
mice
group
seroconvert
antibodi
respons
gag
protein
b
plot
vs
week
number
differ
treg
hbsag
tobaccoimmun
wildtyp
tobaccoimmun
mice
statist
signific
consist
find
pniewski
cowork
pniewski
et
al
immun
mice
low
dose
freezedri
transgen
lettuc
contain
hbsag
without
adjuv
interv
prime
boost
immun
observ
mucos
humor
antihbsag
antibodi
data
coupl
describ
kapusta
et
al
kostrzak
et
al
press
argu
lower
dose
order
avoid
develop
tregmedi
toler
differ
find
obtain
feed
mice
hbsag
transgen
potato
differ
dose
dose
ct
adjuv
three
time
weekli
follow
parenter
boost
hbsag
week
youm
et
al
studi
antihbsag
antibodi
serum
fecal
sampl
increas
direct
relat
oral
dose
differ
result
discuss
kapusta
et
al
kostrzak
et
al
press
may
relat
use
ct
adjuv
oral
dose
parenter
boost
oral
dose
could
suppress
treg
activ
summari
much
work
use
oral
deliveri
plantderiv
hbsag
show
substanti
potenti
vaccin
develop
seem
like
human
use
purifi
prepar
prefer
order
accur
adjust
dosag
optim
level
avoid
possibl
variabl
interf
effect
due
compon
crude
sampl
regard
highlevel
express
facilit
purif
use
viral
replicon
system
benefit
pursuit
mucos
immun
system
capabl
simultan
execut
two
oppos
immun
respons
includ
activ
eg
antigenspecif
neutral
siga
antibodi
quiescent
one
eg
oral
toler
chapter
exampl
oral
immun
protein
antigen
appropri
mucos
deliveri
vehicl
andor
mucos
adjuv
shown
induc
antigenspecif
siga
serum
igg
antibodi
respons
lead
doubl
layer
protect
mucos
invad
pathogen
hand
inject
vaccin
current
commonli
use
field
design
induc
protect
immun
system
compart
aim
induc
mucos
immun
sinc
pathogen
relat
emerg
reemerg
infecti
diseas
eg
vibrio
cholera
rotaviru
hiv
influenza
viru
enterotoxigen
e
coli
infect
host
mucos
surfac
respiratori
digest
tract
mucos
vaccin
like
improv
efficaci
protect
immun
offer
current
parenter
administ
vaccin
could
potenti
prevent
invas
mucos
surfac
pathogen
recogn
cook
rice
edibl
plant
materi
like
denatur
vaccin
antigen
thu
render
poorli
immunogen
order
overcom
challeng
kiyono
cowork
investig
oral
deliveri
rice
flour
deriv
transgen
seed
clinic
examin
safeti
powder
mucoricectb
dissolv
water
healthi
volunt
show
advers
reaction
kiyono
et
al
unpublish
data
phase
clinic
trial
plan
overcom
critic
concern
product
storag
deliveri
vaccin
adapt
transgen
rice
system
use
develop
ricebas
vaccin
mucoric
system
figur
mucoric
system
recent
attract
interest
altern
approach
develop
oral
vaccin
nochi
et
al
tokuhara
et
al
yuki
et
al
rice
seed
edibl
tissu
capabl
produc
store
rel
larg
amount
transgen
recombin
protein
booth
et
al
streatfield
et
al
recombin
protein
express
accumul
rice
seed
stabl
prolong
period
daniel
et
al
anoth
advantag
rice
plant
presenc
two
protein
storag
vacuol
call
protein
bodi
pb
starchi
endosperm
seed
provid
greater
space
accumul
recombin
protein
katsub
et
al
pbi
pbii
distinguish
differ
shape
densiti
protein
composit
yamagata
tanaka
main
storag
protein
pbi
alcoholsolubl
prolamin
eg
prolamin
watersolubl
glutelin
eg
glutelin
accumul
preferenti
pbii
katsub
et
al
yamagata
tanaka
due
water
solubl
protein
pbii
vulner
digest
gastrointestin
tract
protein
store
pbi
pb
system
thought
great
advantag
rice
applic
oral
vaccin
develop
sinc
effect
oral
vaccin
would
benefit
builtin
safeguard
digest
particularli
harsh
acid
environ
stomach
uniqu
natur
protein
storag
system
pbi
pbii
could
use
natur
way
provid
either
slow
immedi
releas
vaccin
antigen
gut
novel
characterist
rice
seed
protein
express
storag
system
use
develop
oral
vaccin
proof
concept
mucoric
vaccin
b
subunit
cholera
toxin
ctb
epitheli
gangliosid
receptorbind
molecul
purpos
select
prototyp
antigen
demonstr
capac
ricebas
mucos
vaccin
induc
system
well
mucos
immun
showcas
practic
use
rice
transgen
express
system
figur
use
transgen
rice
system
accumul
ctb
achiev
approxim
total
seed
protein
seed
weight
higher
stabl
transgen
plant
express
system
eg
potato
tuber
tobacco
leav
arakawa
et
al
daniel
et
al
nochi
et
al
transgen
rice
stabl
harsh
environ
gastrointestin
tract
figur
ricebas
oral
vaccin
induc
protect
immun
diarrheal
diseas
mucoric
system
use
rice
protein
bodi
pb
specif
promot
contain
b
subunit
cholera
toxin
ctb
result
gener
rice
seed
express
ctb
ctb
express
rice
seed
protect
digest
enzym
stabl
prolong
time
eg
month
without
refriger
storag
oral
vaccin
mice
mucoricectb
result
induct
protect
immun
eg
ctbspecif
siga
antibodi
ctinduc
diarrhea
lower
right
show
intestin
mice
treatment
cholera
toxin
ct
rice
seed
possess
protein
storag
organel
pb
use
natur
antigencontain
capsul
examin
abil
ctb
rice
pb
mucoricectb
withstand
digest
enzym
intestin
tract
total
seed
protein
subject
pepsin
treatment
vitro
ctb
accumul
pbi
mucoric
seed
remain
intact
pepsin
treatment
wherea
antigen
accumul
pbii
digest
pepsin
condit
nochi
et
al
shown
vaccin
antigen
express
rice
seed
pb
system
stabl
room
temperatur
sever
year
without
loss
immunogen
nochi
et
al
tokuhara
et
al
mucoric
system
thu
qualifi
suitabl
system
express
accumul
storag
vaccin
antigen
examin
abil
mucoricectb
induc
antigenspecif
immun
respons
mucoricectb
deliv
intestin
immun
system
mice
murin
intestin
tract
contain
peyer
patch
pp
expos
mucoricectb
ricebas
vaccin
taken
profession
antigensampl
cell
locat
follicleassoci
epithelium
pp
success
oral
vaccin
mice
mucoricectb
thu
induc
antigenspecif
mucos
iga
serum
igg
antibodi
respons
show
toxinneutr
activ
thu
prevent
toxininduc
diarrhea
murin
model
nochi
et
al
tokuhara
et
al
furthermor
oral
mucoricectb
vaccin
induc
cholera
toxinneutr
antibodi
nonhuman
primat
mucoric
system
advanc
express
nontox
form
entir
ct
toxin
consist
mutant
b
subunit
demonstr
versatil
mucoric
system
toxinrel
antigen
nontox
fragment
ctermin
half
heavi
chain
botulinum
neurotoxin
type
bohc
express
produc
seed
mucoric
induc
neutral
antigenspecif
antibodi
respons
mice
oral
immun
mucoricebohc
yuki
et
al
anoth
adapt
transgen
rice
seed
system
research
show
express
major
outer
membran
protein
momp
chlamydophila
psittaci
caus
agent
avian
chlamydosi
without
genet
fusion
b
subunit
e
coli
heatlabil
enterotoxin
ltb
zhang
et
al
zhang
et
al
oral
immun
experiment
anim
rice
express
momp
mompltb
result
induct
antigenspecif
protect
immun
ricebas
vaccin
develop
extend
express
virusassoci
antigen
neutral
epitop
porcin
epidem
diarrhea
viru
capsid
precursor
polypeptid
footand
mouthdiseas
viru
glycoprotein
newcastl
diseas
viru
express
rice
seed
show
oral
immunogen
induct
viru
antigenspecif
immun
respons
huy
et
al
wang
et
al
yang
et
al
find
clearli
demonstr
use
attract
rice
transgen
system
develop
cold
chain
syring
needlefre
vaccin
concept
oral
toler
system
unrespons
oral
expos
antigen
consid
attract
logic
strategi
develop
immunotherapi
prevent
andor
treatment
allerg
diseas
cellular
molecular
mechan
oral
toler
yet
precis
clarifi
howev
well
known
prolong
oral
administr
allergen
induc
state
system
unrespons
mucos
expos
allergen
perhap
via
gener
regulatori
cell
galt
purpos
continu
deliveri
allergen
via
oral
rout
induct
oral
toler
transgen
rice
system
adopt
gener
rice
seed
express
allergen
protein
takagi
et
al
minim
undesir
anaphylact
reaction
might
elicit
oral
desensit
process
use
allergen
transgen
rice
plant
express
tcell
epitop
peptid
pollen
allergen
japanes
cedar
eg
cri
j
cri
j
ii
gener
oral
administr
mice
transgen
rice
seed
express
cri
j
cri
j
ii
tcell
peptid
prior
system
challeng
total
cedar
pollen
allergen
result
induct
oral
toler
inhibit
allergenspecif
allergyinduc
helper
respons
support
allergenspecif
ige
respons
takagi
et
al
also
import
note
toler
induc
rice
express
tcell
peptid
cri
j
cri
j
ii
result
inhibit
polleninduc
clinic
symptom
nasal
sneez
murin
inhal
allerg
model
data
support
possibl
adapt
transgen
rice
seed
express
allergenspecif
tcell
epitop
oral
deliveri
induct
oral
toler
pollen
allergenspecif
respons
transgen
rice
system
express
allergen
extend
allerg
asthma
caus
hous
dust
mite
hdm
suzuki
et
al
yang
et
al
major
hdm
allergen
der
der
immunodomin
human
mous
tcell
epitop
express
accumul
rice
pb
system
use
induct
oral
toler
oral
administr
mice
rice
seed
express
hdm
antigen
result
inhibit
allergenspecif
patholog
respons
includ
bronchial
hyperrespons
suzuki
et
al
evid
suggest
rice
transgen
system
use
tool
develop
allergenspecif
mucos
immunotherapi
newli
emerg
human
diseas
past
year
zoonot
ie
anim
origin
season
diseas
influenza
infect
human
livestock
addit
direct
link
anim
human
health
veterinari
diseas
indirectli
affect
public
health
wellb
potenti
devast
impact
food
product
trade
grow
need
develop
safe
effect
afford
veterinari
vaccin
plantbas
product
platform
help
meet
specif
requir
develop
success
econom
viabl
anim
vaccin
cost
product
case
veterinari
vaccin
must
low
order
allow
vaccin
find
broad
use
farm
commun
particularli
develop
countri
vaccin
often
need
product
transgen
plant
scalabl
rel
inexpens
veterinari
vaccin
ideal
stabl
requir
cold
chain
storag
transport
express
vaccin
antigen
plant
storag
organ
seed
tuber
provid
protect
storag
vehicl
easi
rout
administr
allow
vaccin
use
broadli
set
train
veterinari
profession
hand
administr
larg
popul
product
edibl
vaccin
fodder
crop
reconstitut
feed
pellet
allow
easi
administr
feed
importantli
vaccin
must
safe
effect
protect
immun
anim
target
diseas
plantproduct
system
use
express
protect
vaccin
candid
without
risk
contamin
anim
pathogen
sinc
transmiss
rout
mani
anim
pathogen
fecalor
respiratori
direct
contact
result
infect
via
mucos
surfac
vaccin
target
diseas
must
elicit
strong
mucos
immun
respons
order
efficaci
plant
particularli
lend
develop
oral
vaccin
candid
stimul
mucos
immun
sinc
report
first
potenti
plantbas
anim
vaccin
chimer
plantviru
particl
display
epitop
footandmouth
diseas
viru
fmdv
usha
et
al
mani
group
success
use
plant
product
platform
develop
veterinari
vaccin
comprehens
review
streatfield
floss
et
al
nemchinov
rybicki
rybicki
et
al
unit
state
depart
agricultur
usda
licens
first
plantproduc
vaccin
veterinari
vaccin
newcastl
diseas
viru
chicken
dow
agrosci
vermij
set
preced
regulatori
approv
plantmad
vaccin
review
recent
develop
field
plantproduc
mucos
anim
vaccin
particularli
focu
vaccin
four
target
anim
group
bovineovin
porcin
poultri
aquacultur
earli
effort
develop
plantmad
veterinari
vaccin
focus
fmdv
usha
et
al
footandmouth
diseas
day
one
devast
diseas
affect
farm
anim
wild
rumin
worldwid
caus
econom
loss
associ
high
morbid
rate
contain
procedur
involv
cull
movement
restrict
current
vaccin
base
inactiv
viru
safeti
risk
associ
product
fact
vaccin
manufactur
facil
associ
research
laboratori
link
outbreak
fmdv
unit
kingdom
cressey
effort
therefor
focus
develop
inher
safe
subunit
vaccin
plantproduc
fmd
vaccin
candid
base
part
polyprotein
precursor
product
form
fmdv
viral
capsid
variou
strategi
follow
express
epitop
thereof
rang
display
epitop
chimer
plant
viru
particl
usha
et
al
yang
et
al
zhang
et
al
express
hybrid
protein
contain
fmdv
band
tcell
epitop
andrianova
et
al
fusion
report
protein
lentz
et
al
express
fulllength
allow
format
fmdvlike
particl
chimer
vlp
produc
viru
inocul
chenopodium
speci
epitop
display
tobacco
necrosi
viru
tnva
zhang
et
al
bamboo
mosaic
viru
bamv
yang
et
al
similar
yield
mgg
fresh
weight
tissu
fwt
mgg
fwt
achiev
respect
efficaci
prepar
adjuv
test
intramuscular
im
subcutan
inject
swine
follow
challeng
fmdv
result
indic
stimul
high
level
igg
neutral
antibodi
product
full
protect
challeng
even
singl
dose
mg
yang
et
al
test
prepar
perform
mice
via
intranas
rout
without
adjuv
anim
develop
high
titer
serum
igg
iga
well
fecal
vagin
iga
much
immun
respons
rais
carrier
tnv
lower
level
igg
iga
detect
zhang
et
al
challeng
experi
perform
nevertheless
result
indic
mucos
immun
respons
induc
follow
anoth
strategi
full
precursor
polypeptid
fmdv
express
transgen
alfalfa
rice
leav
transient
leav
n
benthamiana
thuenemann
et
al
strategi
du
santo
et
al
express
togeth
proteas
cleav
polyprotein
natur
fmdv
replic
assembl
aim
produc
viruslik
particl
rel
low
express
level
total
solubl
protein
tsp
achiev
transgen
alfalfa
leav
howev
ip
immun
mice
crude
leaf
extract
total
four
inject
adjuv
induc
fmdvspecif
immun
respons
success
protect
mice
challeng
product
fmdv
vlp
also
attempt
transient
coexpress
modifi
fmdv
proteas
cleavag
site
recogn
cowpea
mosaic
viru
proteas
proteas
thuenemann
et
al
though
express
process
detect
vlp
format
observ
recent
wang
et
al
demonstr
oral
immunogen
mice
express
transgen
rice
leav
tsp
serum
igg
mucos
iga
detect
first
week
feed
regimen
five
weekli
dose
antigen
howev
anim
show
viru
clearanc
challeng
one
reason
low
efficaci
oral
deliv
fmdv
vaccin
plant
may
low
express
level
achiev
low
express
level
address
transplastom
express
fmdv
cotransl
fuse
report
lentz
et
al
express
level
tsp
achiev
fusion
protein
abl
induc
serum
igg
product
ip
inject
mice
investig
necessari
determin
whether
describ
fmdv
vaccin
candid
efficaci
target
anim
cattl
sheep
anoth
fusion
protein
consist
band
tcell
epitop
fmdv
express
transient
n
benthamiana
level
tsp
andrianova
et
al
immunogen
studi
guinea
pig
show
format
neutral
antibodi
na
protect
challeng
fmdv
recent
vlpbase
strategi
employ
product
bovin
papillomaviru
bpv
vaccin
candid
transient
express
n
benthamiana
love
et
al
bovin
papillomaviru
tumorigen
cattl
hors
tradit
vaccin
produc
bpv
grown
cultur
viruslik
particl
bpv
produc
express
bpv
protein
yield
fwt
obtain
purif
immunogen
particl
shown
parenter
administr
rabbit
group
india
shown
potenti
plant
product
platform
oral
rinderpest
viru
rpv
pest
de
petit
rumin
viru
pprv
perform
immunogen
studi
target
anim
virus
member
morbilliviru
genu
paramyxovirida
caus
sever
diseas
cattl
small
rumin
respect
khandelw
et
al
express
hemagglutinin
h
protein
rpv
hemagglutininneuraminidas
hn
protein
pprv
transgen
peanut
leav
cattl
fed
g
peanut
leav
express
rpv
h
protein
level
tsp
singl
dose
administ
week
week
elicit
humor
antirpv
respons
na
detect
khandelw
et
al
later
immunogen
test
mice
reveal
oral
vaccin
induc
serum
igg
iga
khandelw
et
al
case
pprv
hn
protein
sheep
fed
similar
way
g
transgen
peanut
leav
week
week
high
level
na
report
first
week
feed
cellmedi
respons
detect
khandelw
et
al
result
demonstr
plantproduc
edibl
vaccin
elicit
strong
immun
respons
larg
anim
howev
case
rinderpest
success
global
rinderpest
erad
programm
start
result
world
organ
anim
health
oie
declar
world
free
rinderpest
therefor
elimin
need
edibl
rpv
vaccin
contrast
increasingli
econom
import
diseas
cattl
bovin
viral
diarrhea
caus
bovin
viral
diarrhea
viru
bvdv
diseas
mainli
associ
fertil
problem
infect
cattl
lead
abort
malform
calv
quest
develop
safer
altern
commerci
avail
inactiv
vaccin
recent
progress
made
two
group
argentina
use
plant
express
system
du
santo
wigdorovitz
report
develop
transgen
alfalfa
plant
express
bvdv
structur
protein
encod
main
antigen
site
du
group
develop
system
fuse
truncat
version
apch
molecul
target
antigen
present
cell
aguirreburuald
et
al
express
level
rel
low
fwt
howev
im
immun
cattl
plant
extract
contain
follow
booster
shot
abl
afford
protect
challeng
bvdv
viru
detect
anim
anoth
group
achiev
higher
express
level
fwt
transient
express
truncat
fusion
nicotiana
tabacum
nelson
et
al
guinea
pig
immun
subcutan
antigen
shown
stimul
product
na
six
seven
anim
interest
see
whether
vaccin
candid
stimul
mucos
respons
cattl
appli
directli
mucosa
research
group
argentina
also
investig
plantbas
product
bovin
rotaviru
brv
lead
caus
diarrhea
neonat
calv
countri
calv
suscept
diseas
within
first
week
birth
therefor
induct
lactogen
immun
prefer
method
protect
wigdorovitz
et
al
report
efficaci
plantproduc
fusion
protein
previous
identifi
peptid
capabl
elicit
protect
respons
wigdorovitz
et
al
fusion
protein
express
transgen
alfalfa
level
tsp
test
suckl
mous
model
pup
born
dam
fed
weekli
month
protect
brv
challeng
group
recent
produc
brv
major
immunogen
determin
transplastom
n
tabacum
level
fwt
fwt
solubl
fraction
test
antigen
suckl
mous
model
lentz
et
al
dam
ip
immun
boost
dam
show
serum
igg
na
respons
pup
challeng
day
birth
protect
compar
control
pup
develop
diarrhea
result
indic
plantbas
vaccin
confer
lactogen
immun
brv
calv
may
possibl
earli
success
product
vaccin
candid
plant
achiev
develop
recombin
rabi
subunit
vaccin
tomato
spinach
tobacco
mcgarvey
et
al
modelska
et
al
yusibov
et
al
oral
immunogen
parenter
protect
efficaci
vaccin
shown
mice
rabi
zoonot
diseas
affect
mammal
worldwid
spread
bite
infect
anim
develop
countri
rabi
repres
particular
health
threat
due
widespread
infect
stray
dog
popul
latin
america
anoth
key
reservoir
rabi
viru
bat
popul
spread
diseas
livestock
recent
lozarubio
et
al
demonstr
oral
efficaci
maizebas
rabi
vaccin
sheep
lozarubio
et
al
sheep
differ
group
fed
singl
dose
ground
maiz
kernel
contain
mg
rabi
viru
g
protein
seed
dose
shown
elicit
na
dose
produc
na
titer
compar
elicit
commerci
inactiv
rabi
vaccin
challeng
lethal
dose
rabi
viru
vaccin
group
achiev
surviv
rate
least
highest
dose
mg
recombin
gprotein
achiev
surviv
rate
inactiv
vaccin
result
show
plantproduc
subunit
vaccin
effect
protect
larg
livestock
anim
rabi
addit
viru
vaccin
plant
also
investig
vaccin
product
platform
protect
livestock
bacteri
pathogen
mannheimia
haemolytica
one
main
causal
agent
pneumon
pasteurellosi
cattl
diseas
worldwid
econom
impact
current
treatment
involv
use
antibiot
prevent
vaccin
would
prefer
lee
et
al
express
outer
membran
lipoprotein
haemolytica
transgen
alfalfa
level
tsp
lee
et
al
immunogen
studi
rabbit
perform
compar
oral
im
applic
wherea
inject
effici
induc
antibodi
product
oral
administr
elicit
immun
respons
one
six
anim
may
due
part
low
express
level
achiev
investig
cattl
undertaken
bacteri
parasit
diseas
addit
sever
viral
diseas
also
target
research
investig
plant
product
platform
porcin
vaccin
research
report
oral
efficaci
plantproduc
vaccin
porcin
cysticercosi
betancourt
et
al
toxoplasma
gondii
et
al
well
product
mucos
immunogen
postwean
diarrhea
kolotilin
et
al
porcin
cysticercosi
pig
tapeworm
caus
parasit
taenia
solium
vaccin
consist
three
peptid
produc
transgen
papaya
callu
hernandez
et
al
rabbit
receiv
oral
administr
mg
callu
boost
day
challeng
taenia
pisiformi
close
relat
solium
day
upon
sacrific
anim
research
found
reduct
hepat
lesion
reduct
cysticerci
recov
therebi
show
effici
protect
rabbit
betancourt
et
al
anoth
econom
import
parasit
pig
well
human
warmblood
anim
livestock
gondii
caus
toxoplasmosi
infect
host
gut
mucosa
gondii
antigen
express
transplastom
n
tabacum
level
fwt
suspens
lyophil
leaf
extract
use
oral
immun
mice
gavag
et
al
mice
oral
challeng
later
sacrif
enabl
brain
examin
experi
show
induct
system
mucos
immun
respons
reduct
brain
cyst
load
compar
control
addit
parasit
diseas
bacteri
postwean
diarrhea
caus
enterotox
e
coli
etec
recent
target
kolotilin
et
al
express
etec
fimbrial
adhesin
faeg
high
level
tsp
transplastom
tobacco
tsp
transient
chloroplasttarget
express
n
benthamiana
kolotilin
et
al
author
show
antigen
could
surviv
extend
incub
simul
gastric
intestin
fluid
indic
stabil
gastrointestin
tract
suitabl
oral
immunogen
porcin
edema
diseas
also
caus
e
coli
shiga
toxin
b
subunit
recent
express
transgen
lettuc
matsui
et
al
oral
immunogen
experi
swine
current
progress
porcin
diseas
current
target
plantbas
vaccin
caus
virus
one
earliest
exampl
product
glycoprotein
porcin
transmiss
gastroenter
viru
tgev
arabidopsi
thaliana
immunogen
mice
follow
im
inject
et
al
host
plant
compat
largescal
product
antigen
therefor
group
express
protein
transgen
n
tabacum
maiz
tuboli
et
al
lamphear
et
al
maizeproduc
tgev
protein
mgkg
seed
shown
induc
na
oral
immun
sow
na
also
detect
milk
farrow
lamphear
et
al
show
potenti
lactogen
immun
piglet
furthermor
passiv
immun
piglet
achiev
oral
applic
plantproduc
small
immun
protein
sip
target
tgev
monger
et
al
transient
express
use
produc
sip
level
tsp
cowpea
anim
receiv
daili
oral
dose
resuspend
lyophil
plant
extract
show
reduct
tgev
viru
titer
gut
lung
well
reduc
pulmonari
lesion
compar
control
group
sever
group
recent
investig
efficaci
plantproduc
subunit
vaccin
porcin
reproduct
respiratori
syndrom
prr
diseas
first
recogn
becom
one
import
diseas
farm
pig
north
america
europ
becom
problem
part
world
particularli
asia
current
commerci
vaccin
target
caus
agent
porcin
reproduct
respiratori
syndrom
viru
prrsv
either
limit
efficaci
kill
viru
vaccin
carri
inher
risk
revers
modifiedl
viru
vaccin
therefor
altern
safe
efficaci
vaccin
desper
need
group
taiwan
first
express
prrsv
envelop
glycoprotein
major
target
neutral
antibodi
well
fusion
protein
transgen
n
tabacum
chia
et
al
chia
et
al
oral
immunogen
efficaci
studi
pig
demonstr
induct
serum
igg
salivari
iga
second
administr
well
reduc
viral
load
organ
reduc
clinic
diseas
sign
intranas
challeng
prrsv
howev
yield
studi
low
ngg
fwt
improv
yield
achiev
express
transgen
potato
fwt
leav
fwt
tuber
immunogen
confirm
intragastr
immun
mice
chen
liu
group
recent
report
express
immunogen
nucleocapsid
protein
n
produc
transgen
soybean
vimolmangkang
et
al
matrix
protein
produc
transgen
maiz
callu
product
antigen
soybean
maiz
benefit
easi
storag
without
cold
chain
howev
experi
need
show
efficaci
vaccin
candid
vaccin
viral
diseas
relev
swine
industri
investig
product
plant
limit
success
one
exampl
classic
swine
fever
viru
csfv
relat
bvdv
cattl
caus
sever
acut
ill
pig
result
fever
loss
appetit
diarrhea
high
mortal
rate
strategi
vaccin
product
plant
focus
csfv
glycoprotein
either
subunit
vaccin
et
al
legocki
et
al
epitop
display
chimer
vlp
potato
viru
x
marconi
et
al
studi
one
abl
show
induct
serum
igg
fecal
iga
oral
immun
mice
legocki
et
al
anoth
exampl
porcin
epidem
diarrhea
viru
pedv
coronaviru
relat
tgev
caus
less
sever
symptom
subunit
vaccin
candid
base
neutral
epitop
tgev
spike
protein
coe
express
transgen
n
tabacum
shown
stimul
product
specif
serum
igg
fecal
iga
administ
oral
mice
bae
et
al
similar
approach
involv
ricebas
express
fusion
protein
coe
ltb
oszvald
et
al
coe
celltarget
ligand
huy
et
al
latter
show
weak
induct
serum
igg
fecal
igg
administ
mice
gavag
challeng
experi
pedv
test
target
anim
need
perform
determin
efficaci
vaccin
candid
recent
surg
interest
plant
product
platform
poultri
vaccin
may
part
due
usda
approv
plant
cell
culturebas
vaccin
newcastl
diseas
viru
ndv
chicken
vermij
though
vaccin
market
signific
mileston
regulatori
approv
plantproduc
vaccin
pharmaceut
gener
addit
ndv
target
recent
develop
plantbas
poultri
vaccin
candid
includ
infecti
bursal
diseas
viru
ibdv
avian
reoviru
c
psittaci
causal
agent
chicken
coccidiosi
infecti
bursal
diseas
econom
import
diseas
worldwid
caus
either
subclin
infect
lead
longlast
immunosuppress
acut
clinic
infect
high
mortal
rate
main
immunogen
determin
ibdv
express
thaliana
rice
wu
et
al
wu
et
al
feed
chicken
g
transgen
rice
grain
four
occas
induc
product
igg
na
challeng
ibdv
afford
better
protect
format
bursal
lesion
liveattenu
commerci
vaccin
administ
intranas
recent
differ
strategi
seen
present
antigen
bamboo
mosaic
viru
particl
chimer
vlp
shown
induc
ibdvspecif
serum
igg
im
inject
chicken
result
indic
plantbas
mucos
vaccin
ibdv
may
provid
good
altern
commerci
vaccin
chlamydophila
psittaci
causal
agent
avian
chlamydiosi
zoonot
diseas
caus
respiratori
symptom
bird
well
human
transgen
rice
seed
use
express
c
psittaci
momp
well
fusion
momp
ltb
zhang
et
al
though
express
level
low
approach
tsp
mompspecif
humor
mucos
immun
respons
detect
oral
applic
plantproduc
momp
mice
zhang
et
al
zhang
et
al
addit
serum
igg
fecal
iga
induct
cytokin
report
despit
posit
result
approxim
anim
protect
challeng
aerosolcontain
c
psittaci
chicken
coccidiosi
caus
protozoan
eimeria
genu
caus
variou
speciesdepend
symptom
associ
damag
intestin
mucosa
widespread
use
anticoccidi
drug
led
develop
resist
therefor
safe
effect
lowcost
vaccin
need
control
diseas
recent
sathish
et
al
report
plantbas
transient
express
eimeria
tenella
vacuum
infiltr
n
tabacum
sathish
et
al
sathish
et
al
chicken
immun
im
inject
challeng
oral
inocul
sporul
oocycst
research
found
induct
serum
igg
reduct
oocyst
shed
significantli
higher
weight
gain
compar
unvaccin
challeng
anim
interest
see
whether
administr
vaccin
candid
via
mucos
rout
enhanc
protect
efficaci
recent
progress
also
made
develop
plantmad
natur
recombin
adjuv
immun
stimul
use
poultri
sector
natur
ginseng
stemandleaf
saponin
tradit
chines
herbal
medicin
found
enhanc
immunogen
commerci
mucos
ndv
vaccin
administ
oral
water
day
vaccin
zhai
et
al
anoth
group
shown
safeti
immunogen
plantproduc
mutant
e
coli
heat
labil
holotoxin
use
adjuv
poultri
industri
miller
et
al
combin
adjuv
stimul
plantmad
poultri
vaccin
candid
describ
may
help
formul
efficaci
vaccin
sector
rel
new
area
applic
plantproduc
vaccin
aquacultur
industri
farm
fish
aquat
organ
gain
increas
import
mani
sea
becom
overfish
intens
fish
farm
bring
increas
risk
diseas
must
dealt
effici
costeffect
manner
infe
deliveri
vaccin
one
potenti
method
protect
fish
stock
without
laborintens
applic
public
provid
first
indic
oral
immun
fish
plantproduc
antigen
could
work
companjen
et
al
use
transgen
potato
plant
express
two
model
fusion
protein
antigen
e
coli
heatlabil
toxin
b
ltb
fuse
either
gfp
ltbgfp
epitop
influenza
ha
canin
parvoviru
ltbp
companjen
et
al
oral
administr
incorpor
ltbgfp
potato
food
pellet
induc
antigfp
antibodi
respons
carp
anal
intub
carp
extract
ltbp
potato
induc
antiparvoviru
respons
first
administr
result
provid
good
indic
oral
immun
fish
possibl
use
plantproduc
antigen
howev
studi
use
antigen
deriv
relev
fish
pathogen
well
challeng
experi
need
perform
recent
group
thailand
report
protect
shrimp
infect
white
spot
syndrom
viru
wssv
im
coinject
wssv
viral
bind
protein
produc
thaliana
suspens
cultur
thagun
et
al
shrimp
possess
develop
immun
system
therefor
classifi
vaccin
howev
indic
grow
accept
plantproduc
pharmaceut
use
aquacultur
use
plant
product
recombin
protein
substanti
evolv
past
year
first
plantbas
vaccin
express
stabli
transgen
plant
idea
conveni
deliv
edibl
vaccin
ingest
antigencontain
plant
materi
system
provid
proof
concept
oral
deliveri
vaccin
crude
plant
materi
could
stimul
antigenspecif
serum
mucos
antibodi
sever
clinic
trial
shown
potenti
plantderiv
oral
deliv
vaccin
human
use
raw
potato
tuber
conveni
model
system
difficulti
implement
potato
tuber
system
led
use
transgen
grain
rice
corn
maiz
mucoric
express
ctb
emerg
strong
candid
clinic
trial
provid
stabl
robust
vehicl
oral
antigen
deliveri
moreov
transgen
grain
strong
potenti
use
edibl
vaccin
agricultur
anim
swine
poultri
sever
studi
support
idea
challeng
issu
exist
stabli
transgen
plant
includ
rel
low
express
level
regulatori
issu
relat
use
human
food
crop
host
thu
mani
recent
studi
use
transient
express
plant
viral
vector
achiev
rapid
highlevel
express
nonfood
plant
n
benthamiana
follow
purif
antigen
protein
deliveri
purifi
protein
oral
intranas
rout
result
robust
stimul
system
mucos
immun
respons
studi
examin
potenti
novel
adjuv
mucoadhes
immunemodul
molecul
mucos
deliveri
promis
result
conclus
use
plant
product
mucos
deliveri
vaccin
antigen
grown
tremend
research
laboratori
around
world
accept
plantbas
technolog
vaccin
industri
may
yet
year
away
like
occur
safeti
efficaci
studi
prove
worth
